ClinicalTrials.gg
Sign In
Status unknownNCT03670108Updated Sep 13, 2018

"SMS - Heals My Health"

An observational study in to Help Improve the Quality of Life of Patients, sponsored by Hôpital Cochin. Status unknown at 1 site in France. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2018-09-13.

Sponsored by Hôpital Cochin · Observational

The sponsor has not verified this record recently (last verified Sep 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
200
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Therapeutic patient education is an approach that has shown its usefulness in rheumatology, but the duration of its impact is limited, and therapeutic revisions are regularly necessary. The practice of physical activity is one of the goals of TPE in rheumatology and new technologies, such as SMS messages represent a possible complementary tool to amplify behavioral changes The study primary objective is to evaluate the impact of individualized SMS compared to standard SMS messages on the physical activity of patients with chronic inflammatory rheumatism or osteoporosis, included in a therapeutic education program. Our hypothesis is that individualized SMS has a higher efficiency compared to standard SMS messages to increase the practice of physical activity in these patients.

02

Conditions studied

  • to Help Improve the Quality of Life of Patients
03

In context

Lead sponsor

Hôpital Cochin is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients with osteoporosis or inflammatory rheumatism aged between 18 and 75 years, who participated in the patient's therapeutic education program

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patient age from 18 to 75 years
  • Participated in therapeutic patient education program osteoporosis disease and inflammatory rheumatism disease
  • Having given their written consent
  • French speaking
  • Possessing a telephone tool that accepts SMS

Exclusion criteria

Exclusion Criteria:

  • Patients unable to read SMS for practical, linguistic or cognitive reasons
  • Patients who can not, for medical reasons or disability, set up 30 minutes of moderate physical activity (walking or other moderate activity) per day
  • Having already participated in a similar study in inflammatory rheumatism or osteoporosis
  • Already having the required level of physical activity: performing more than 30 minutes of moderate physical activity (walking or other moderate activity)
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients receiving an individualized SMS
  • patients receiving a standard SMS
06

What researchers measure

Primary outcomes

  1. physical activity

    evaluate the percentage of patients reaching 30 minutes of moderate physical activity

    Time frame: 1 YEAR

07

Study locations

1 of 1 sites recruiting
  • Cochin Hospital
    Paris, 75014, France
    Recruiting
    • TERKIA MEDKOUR, PHD · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 13, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03670108
Lead sponsor
Hôpital Cochin
Responsible party
Serge Perrot (professor, Hôpital Cochin) — Principal investigator
First posted
Sep 13, 2018
Start date
Jan 12, 2018
Primary completion
Feb 12, 2019 (estimated)
Completion
Jan 12, 2020 (estimated)
Last update
Sep 13, 2018

Study contacts

Terkia MEDKOUR, PHD
Contact
terkia.medkour@aphp.fr
0033158411507

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Hôpital Cochin

Start the discussion